International trade · 27/08/2026

Castle Biosciences Files Complaint with U.S. International Trade Commission Over Melanoma Diagnostic Tests

Castle Biosciences, Inc. has filed a complaint with the U.S. International Trade Commission alleging unfair competition and false advertising by companies selling melanoma predictive and prognostic tests, filed on July 10, 2026.